4 authorised products containing Mosunetuzumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Lunsumio 1 mg concentrate for solution for infusion EU/1/22/1649/001 |
Mosunetuzumab | Roche Registration GmbH | — |
| Lunsumio 30 mg concentrate for solution for infusion EU/1/22/1649/002 |
Mosunetuzumab | Roche Registration GmbH | — |
| Lunsumio 45 mg solution for injection EU/1/22/1649/004 |
Mosunetuzumab | Roche Registration GmbH | — |
| Lunsumio 5 mg solution for injection EU/1/22/1649/003 |
Mosunetuzumab | Roche Registration GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.